For research use only. Not for therapeutic Use.
Lemzoparlimab (TJ011133; TJC4) is a humanized anti-CD47 IgG4 antibody. Lemzoparlimab has a strong anti-tumor activity[1].
| Catalog Number | I043773 |
| CAS Number | 2377483-71-9 |
| Purity | ≥95% |
| Reference | [1]. Amitkumar Mehta, et al. Lemzoparlimab, a Differentiated Anti-CD47 Antibody in Combination with Rituximab in Relapsed and Refractory Non-Hodgkin’s Lymphoma: Initial Clinical Results. Blood (2021) 138 (Supplement 1): 3542. |
